The role of residues in the conserved hydrophobic N-terminal fusion peptide of the paramyxovirus fusion (F) protein in causing cell-cell fusion was examined. Mutations were introduced into the cDNA encoding the simian virus 5 (SV5) F protein, the altered F proteins were expressed by using an eukaryotic vector, and their ability to mediate syncytium formation was determined. The mutant F proteins contained both single-and multiple-amino-acid substitutions, and they exhibited a variety of intracellular transport properties and fusion phenotypes. The data indicate that many substitutions in the conserved amino acids of the simian virus 5 F fusion peptide can be tolerated without loss of biological activity. Mutant F proteins which were not transported to the cell surface did not cause cell-cell fusion, but all of the mutants which were transported to the cell surface were fusion competent, exhibiting fusion properties similar to or better than those of the wild-type F protein.
Mutant F proteins containing glycine-to-alanine substitutions had altered intracellular transport characteristics, yet they exhibited a great increase in fusion activity. The potential structural implications of this substitution and the possible importance of these glycine residues in maintaining appropriate levels of fusion activity are discussed.
Penetration of enveloped viruses into a host cell occurs by means of direct fusion of the viral envelope with cellular membranes, resulting in delivery of the viral genome (in the form of a capsid or nucleocapsid) into the cytoplasm of the target cell. A large body of data for viruses such as orthomyxoviruses, togaviruses, rhabdoviruses, bunyaviruses, and some retroviruses indicates that, following attachment of the virus to a cell surface receptor, the viruses are endocytosed and transported to a low-pH endosomal compartment where the low pH triggers the fusion of the viral envelope with the cellular plasma membrane, releasing the viral genome into the cytoplasm. For other viruses, such as paramyxoviruses, herpesviruses, coronaviruses, and human immunodeficiency virus, the majority of the available evidence indicates that the viral envelope fuses directly with the cellular plasma membrane, releasing the viral genome into the cytoplasm. In all cases, fusion of the viral envelope with a cellular membrane is mediated by a viral envelope glycoprotein (reviewed in references 58, 66, and 67 ). An important consequence of virus-induced fusion at neutral pH is cell-tocell fusion causing the intercellular spread of virus, the formation of syncytia, and subsequent cell death.
The fusion (F) glycoprotein of paramyxoviruses is a type I integral membrane protein that has been shown to be involved in virus penetration, hemolysis, and cell fusion (16, 52) . The F protein is synthesized as an inactive precursor (FO) that is cleaved by a host cell proteolytic enzyme to form the biologically active protein consisting of the disulfidelinked chains F, and F2, resulting in the release of the new N terminus of F, (52) (53) (54) . Detergent binding and spectroscopic studies indicate that cleavage of Fo causes a conformational change in the molecule, resulting in the exposure of previously solvent-inaccessible hydrophobic domains, and that there is a concomitant increase in the a-helical nature of the * Corresponding author.
protein (20) . Both protein sequencing studies of the F protein and nucleotide sequencing studies of the cDNA of the F protein genes of many paramyxoviruses indicate that the N-terminal 20 residues of F, are extensively hydrophobic and this region of the F protein is highly conserved among paramyxovirus F proteins (up to 90% identity; see Fig. 1A ) (54; reviewed in reference 31). This led to the suggestion that the N-terminal region of F, (fusion peptide) is directly involved in promoting fusion with the target membrane (13, 46, 54) . Evidence in support of this notion includes the finding that synthetic peptides that mimic the fusion peptide sequence inhibit both cell fusion and virus penetration (45, 46) . In addition, the fusion peptide is sufficiently hydrophobic to act as an anchor (stop-transfer domain) of a heterologous membrane protein (39) , indicating that the fusion peptide can form stable interactions with membranes. Other evidence that the fusion peptide can interact with target lipid bilayers was obtained by labeling it with photoactive lipid probes (2, 34) .
It has been shown previously that the paramyxovirus simian virus 5 (SV5) F gene cDNA (37) , when expressed in CV-1 cells by using SV40 recombinant viruses, is biologically active, causing syncytium formation (38, 41) . Thus, this provides an assay system in which the contribution of residues ln the fusion peptide to syncytium formation can be tested. The invariant nature of many of the residues of the fusion peptide between paramyxovirus F proteins suggests a role more complex than preservation of hydrophobic residues required for a membrane-intercalating domain: neither signal sequences nor membrane anchorage domains show sequence conservation beyond their hydrophobic nature (64) . It has been noted that if the fusion peptide is assumed to be an ox-helix, then the invariant residues are located on one face of the helix (Fig. 1B) (55) . The significance of this is unknown, but it is of interest that membrane spanning domains of proteins are usually thought to be ao-helical regions based on theoretical predictions and also 2, 22; 3, 62; 4, 65; 5, 44; 6, 61; 7, 63; 8, 28; 9, 57; 10, 27; 11, 19. (B) Helical wheel representation of the SV5 F1 fusion peptide showing residues changed by mutagenesis. The amino acids of the F1 amino terminus are numbered; italics indicate the invariant amino acid residues. Point mutations constructed and described in this work are shown by arrows, with the new residue indicated.
because the membrane spanning domains of bacterial photosynthetic reaction centers are known to form a-helices (1, 7, 49) .
To test the requirement for sequence conservation in the fusion peptide of the F protein of SV5 for biological activity, mutations were introduced into the F cDNA to alter both invariant and variant amino acids. In addition, as glycine is a known ox-helix destabilizing residue (26) , the three glycines in the fusion peptide were converted to alanine residues, a change that has the propensity to increase the a-helical nature of a peptide (59) . Cells and viruses. Monolayer cultures of the TC7 subclone of CV-1 cells (42) were grown in Dulbecco's modified Eagle's medium (DME) containing 10% NU-Serum IV (Collaborative Research Laboratories, Inc., Bedford, Mass.). Cells were infected with SV40 recombinant virus and SV5 (W3A strain) as described previously (38) .
Construction of mutant F proteins and SV40 recombinant viruses. The SV40 late region replacement vector containing the SV5 F cDNA (pSV103F) has been described previously (38) . The Asp-718-BamHI fragment from pSV103-F, which contains SV40 sequences and F sequences encoding the fusion peptide, was subcloned into bacteriophage M13 and used for oligonucleotide-directed mutagenesis as described previously (41) . The template single-stranded DNA for mutagenesis was uracil enriched (23) , and mutagenesis was done as described previously (18 [lI) . For pulse-chase experiments, cells were washed twice in phosphate-buffered saline (PBS), incubated in prewarmed DME Met-Cys-for 30 min, and then labeled with 200 ,Ci of Tran35S-label per ml for the pulse period indicated. The chase period was initiated by removal of the labeling medium, washing, and replacement with prewarmed chase medium (DME supplemented with 2 mM unlabeled cysteine and methionine and 2% NU-Serum IV), and the cells were incubated for various periods. Cells were lysed in ice-cold RIPA buffer containing protease inhibitors and 25 mM iodoacetamide.
F polypeptides were immunoprecipitated from cell lysates by using a rabbit antiserum raised against a mixture of three synthetic peptides specific for F2 residues 22 to 39, 31 to 46, and 77 to 94; this antiserum was kindly provided by Reay Paterson. Immunoprecipitations were performed as described previously (25) . To test for conversion of N-linked carbohydrate chains from the high-mannose form to the complex form, immune complexes on protein A-Sepharose beads were digested with 1 mU of endo H (BoehringerMannheim Biochemicals, Indianapolis, Ind.) as described previously (33) .
Polypeptides were analyzed by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) on 15% gels in the presence or absence of dithiothreitol, and gels were processed for fluorography as described previously (24) . Autoradiograms were quantitated by using a laser (43), was used as the primary antibody at a 1:500 dilution in 1% BSA-PBS, and fluorescein isothiocyanate-conjugated goat anti-mouse IgG (Organon Teknika-Cappel, Malvern, Pa.) was used as the secondary antibody. Incubation conditions for immunofluorescence microscopy were used as described previously (9), and cells were photographed with a Nikon Microphot-FXA microscope system (Nikon Corp., Tokyo, Japan).
For flow cytometry, culture dishes (6 cm) of SV40 recombinant virus-infected CV-1 cells were chilled on ice, and the cells were washed with ice-cold PBS containing 0.02% sodium azide (PBSN). MAb Fla was added to the monolayer at 1:500 dilution in PBSN containing 1% BSA, and the mixture was incubated on the plate for 30 min at 4°C. The cell monolayers were washed five times with PBSN, incubated with fluorescein isothiocyanate-conjugated goat antimouse IgG for 30 min at 4°C, and washed five times with PBSN and two times with PBS deficient in calcium and magnesium (PBS-) to remove unbound secondary antibody. To remove cells from the dish, PBS containing 50 mM EDTA (0.5 ml) was added and cells were incubated at 4°C until they dissociated easily from the plate with aspiration. Cells were transferred to flow cytometry tubes containing 0.5 ml of 1% methanol-free formaldehyde and dispersed by pipetting. Fluorescence intensity of 10,000 cells was measured by a FACSCAN flow cytometer (Becton Dickinson, Mountain View, Calif.).
Assessment of extent of fusion and antibody-mediated inhibition of syncytium formation. Mutant F proteins expressed by using SV40-recombinant viruses were assessed for the ability to mediate syncytium formation in CV-1 cells as described previously (38) . Syncytia were photographed at 48 h p.i. by using a Nikon Diaphot inverted phase-contrast microscope and Kodak T-MAX film (Eastman Kodak Co., Rochester, N.Y.).
To inhibit syncytium formation, CV-1 cells infected with SV40 recombinant viruses were washed at 24 h p.i. with PBS, and the medium was replaced with 2 ml of DME-2% NU-Serum IV containing a 1:50 dilution of MAb Fla ascites fluid. Cells were incubated for a further 24 h. As a control for nonspecific inhibition, an irrelevant antibody (MAb 14C2 specific for the influenza virus M2 protein ectodomain [681) was overlaid onto parallel plates at equal dilution.
Measurement of the area of the syncytia caused by the different SV40 recombinant viruses was facilitated by using Sigma Scan scientific measurement system hardware and software (Jandel Scientific, Corte Madera, Calif.). Photomicrographs of smncytium-containing fields (at least three fields of 1.04 x 10 P.m2 in area, totalling 7 to 70 syncytia per recombinant virus stock) of cells were enlarged to optimize accurate tracing of the syncytia during electromagnetic digitization of the images. A scale calibration standard was provided by enlargement of the image of a stage micrometer photographed under identical conditions.
RESULTS
Mutagenesis rationale and expression of the altered F proteins. To test the requirements for sequence conservation in the paramyxovirus F1 protein N-terminal domain, selected mutations were made in the F peptide by oligonucleotidedirected mutagenesis of a cDNA clone of the paramyxovirus SV5 F gene. The mutants contained the following changes: hydrophobic residues substituted for different hydrophobic residues (F1L, V5L, A1oV, and V13I, using a nomenclature system in which the first letter specifies the original residue, the number specifies its position in the fusion peptide, and the following single letter specifies the substituted residue), a polar residue changed to an aliphatic residue (T15V), conversion of the three glycine residues to alanine which should theoretically make the fusion peptide more a-helical (G3A, G7A, and G12A), shortening of the length of the hydrophobic sequence by introduction of a charged residue at position 12 or 18 (G12E, Q18E, and Q18K), and substitution of glutamine by asparagine (Q18N), which also adds a site for the potential addition of N-linked carbohydrate. In addition, two more radical changes were made: mutant A1oV-G12A-A14I (V1O A12I14) contains three changes and makes the fusion peptide slightly more hydrophobic, and mutant TAVGLA1-15 contains a reversal of the order of the conserved sequence of residues 10 to 15 (Fig. 1A) . The change F1L occurs naturally in the F protein of some strains of Newcastle disease virus (60) , so this change was not expected to cause a large difference in phenotype. The single-residue changes are shown in Fig. 1B , with the fusion peptide sequence modeled as an a-helix. It can be seen that the mutations involve residues that are on both the variant and invariant face of the putative helix.
The altered F cDNAs were expressed in CV-1 cells by using an SV40 late-region replacement vector as described previously (38, 41 (32, 50) . The rate of intracellular transport of SV5 wt F expressed from the SV40 vector has not been reported, but cell surface antibody binding studies show it occurs before arrival at the cell surface (36) . Thus, the rate at which carbohydrate chains obtained resistance to digestion with endo H, indicative of transport to the medial Golgi, and its temporal relationship to F cleavage were determined. SV40 wt F recombinant virus-infected CV-1 cells were pulse-labeled with Tran35S-label for 10 min and incubated for various periods. Polypeptides were immunoprecipitated, treated with or without endo H, and analyzed by SDS-PAGE. Samples were subjected to electrophoresis under nonreducing conditions to examine the endo H-sensitive and -resistant species (as Fo and F1,2 migrate as a single band on the gel) and under reducing conditions to examine the cleaved products. As shown in Fig. 3A , the F-related species acquired resistance to digestion with endo H with a half-life (tl2) 45 (Fig. 4) . For C. by densitometric analysis, and the data were plotted as the percentage of total F-specific radioactive material remaining as Fo.
those molecules of A1OV that were cleaved (-70% of total) the rate of cleavage was slightly slower than that for wt F.
The remaining 30% of the A1OV molecules were not cleaved in a 270-min chase period. Fluorescent staining with the anti-F MAb indicated that all these mutants were expressed at the cell surface, and quantification of the surface fluorescence by flow cytometry indicated that the fluorescent intensities were similar (within a twofold difference) to that found for wt F (data not shown).
The kinetics of transport of the glycine mutants G3A, G7A, and G12A, although different from each other, are considered together not only because of the similarity of the mutation but because of their similar biological phenotypes (see below). Mutants G3A and G7A had rates of acquisition of carbohydrates resistant to digestion with endo H that were very similar to that for wt F (Fig. SA) . However, no endo H-resistant species could be detected with expression of mutant G12A, suggesting it is blocked in transport to the medial Golgi apparatus. When the cleavage of the glycine mutants was examined, it was found that G3A was cleaved at a rate similar to that for wt F. In contrast, mutant G7A seemingly consisted of a population of molecules that was cleaved with somewhat slower kinetics than those of wt F and a population of G7A molecules that remained uncleaved in a 270-min chase period. As expected from the lack of resistance to endo H, no cleavage of G12A could be detected (Fig. 5B) . The kinetic analysis of G7A transport was complicated by the finding that between 60 and 90 min after the pulse-label, the total amount of endo H-resistant G7A and the amount of both uncleaved and cleaved G7A declined, indicating G7A is relatively unstable compared with wt F (Fig. 5C) . From the quantitation of the rates of resistance of G7A to endo H digestion, cleavage, and stability, it can be deduced that degradation of G7A approximately coincides with the time of F cleavage. This finding that the cleaved F1 and F2 of mutant G7A are unstable may cause an exaggeration of the amount of Fo found to remain after the 120-min chase period (Fig. 5B) V5L, A1oV, V131, and Q18E, which were transported intracellularly, caused syncytium formation (Fig. 6 ). Mutants G3A, G7A, and G12A caused large areas of syncytium formation (Fig. 6 ). This was unexpected given the impaired intracellular transport of G7A, with its instability in the cleavage compartment, and for G12A, with the seeming lack of any detectable intracellular transport. The surface area (in square micrometers) of the monolayer covered by the syncytia was quantitated by morphometric analysis as described in Materials and Methods. As shown in Fig. 7 , expression of mutants F1L, V5L, A1oV, V13I, and Q18E did not cause a large difference in the percentage of the area of CV-1 cell monolayers that was involved in syncytium formation versus that observed with wt F expression (fusion of wt F = 3%).
However, mutants G3A, G7A, and G12A caused 16.6, 37.4, and 47.2%, respectively, of the monolayer area to be involved in syncytium formation (Fig. 7) . Cleavage and cell surface expression of mutants G3A, G7A, and G12A. Although intracellular transport of G7A was impaired and G12A could not be detected in the metabolic labeling experiments, the fusion observed made it important to use a more sensitive immunoblotting assay to search for an accumulation of cleaved F molecules. Equal amounts of lysates from cells expressing wt F, G3A, G7A, G12A, and V5L were subjected to SDS-PAGE. In alternating lanes of the gel, uninfected cell lysates were analyzed. The polypeptides were transferred to nitrocellulose membranes and immunoblotted by using anti-F2 serum and 125I-labeled secondary antibody. As shown in Fig. 8 slightly greater than that of G7A even though in the kinetic analysis cleavage of G12A to F1 and F2 was not detected whereas G7A cleavage products were readily detected (Fig.  5B ). This can be explained because in the blot analysis, accumulation of F species synthesized over 48 h is analyzed and a large proportion of G7A is degraded at a time point almost coincident with cleavage (Fig. SC) .
To examine for cell surface expression of G3A, G7A, and G12A, the cell surface was stained with the anti-F MAb.
Whereas cells expressing wt F or G3A exhibited a bright surface staining pattern, those expressing G7A and G12A showed a much weaker and diffuse staining pattern (Fig.  9A ). This decreased fluorescent staining is unlikely to be due to differences in reactivity of the mutant proteins for the Fla MAb, as very similar data was obtained by using an F-specific polyclonal rabbit sera (data not shown). Quantitation of the relative Fla-specific surface fluorescence intensity by flow cytometry demonstrated intense fluorescence for wt F and G3A and greatly reduced staining for mutants G7A and G12A (G7A is 15% of wt F and G12A is 23% of wt F [Fig.  9B]) . Thus, the cell surface staining intensity of G7A and G12A in comparison to wt F, like the amount of F2 that accumulated, correlated inversely with increased fusion activity of the mutants.
F MAb inhibition of syncytium formation. It has been shown previously that antibody to F protein can inhibit cell-to-cell fusion (29, 30) and cause virus neutralization (40, 43) . To show that the fusion observed in cells expressing G3A, G7A, and G12A was due to F molecules that were expressed at the cell surface and was not due to trivial causes, the Fla MAb was added to CV-1 cells infected with the SV40 F recombinant viruses at 24 h p.i., a time when no fusion could be detected. As a control for nonspecific effects, ascites fluid of an irrelevant MAb (14C2, specific for the ectodomain of influenza A virus M2 protein [68]) was used. As shown in Fig. 10 , whereas the control cells showed extensive syncytium formation at 48 h p.i., the F MAb inhibited fusion. The low-power-magnification photograph of the cells incubated without antibody is shown (Fig. 10) to illustrate better the extent of syncytium formation across a greater area of cells.
DISCUSSION
Although virus-mediated cell fusion is a phenomenon that has been observed over many decades, little is known about the mechanistic details of the initial interactions between the viral fusion proteins and the lipid bilayer which lead to membrane coalescence. Several viral fusion proteins share the common feature of requiring proteolytic processing for activation of the fusion activity and have a hydrophobic domain following the newly released N terminus that is relatively glycine rich, e.g., influenza virus HA2 N-terminal region and human immunodeficiency virus gp4l and simian immunodeficiency virus (SIV) gp32 N-terminal regions (4, 11, 12) . With the paramyxoviruses, cleavage of the F protein generates a new N terminus on the F1 subunit, and it has been speculated that the released highly conserved hydrophobic fusion peptide domain can disrupt membrane integrity by direct interaction with the lipid bilayer (13, 34, 54) . To examine the effect of alterations in the conserved fusion domain on syncytium formation, site-specific mutations (summarized in Table 1 ) were made in the paramyxovirus SV5 F protein fusion peptide.
The biological activity of the F protein as determined by syncytium formation can only be measured if the F protein is expressed at the cell surface. Over the past several years it has been established for several integral membrane proteins that proper folding and oligomerization are prerequisites for transport from the endoplasmic reticulum (ER) to the Golgi cistemae (reviewed in reference 48). Many point mutations have been shown to lead to malfolded proteins that are retained in the ER. However, some mutants are efficiently exported from the ER but they are still blocked in transport to the cell surface: mutants in the cytoplasmic tail of VOL. 66, 1992 on October obtained which were transport competent but defective in fusion activity, analogous to the substitution of glutamic acid for glycine at residue 4 of the influenza virus HA2 F peptide which rendered a transport-competent but fusion-defective molecule (12) .
Our quantitation of cell fusion was based on the relative syncytium-inducing capacity observed for the mutant SV5 F proteins when expressed from an SV40 vector. Although viral F proteins do not always induce syncytia, the SV5 F protein causes fusion in many but not all cell types when expressed because of SV5 infection of cells or from vectorbased cDNA expression systems (15, 38, 40) . It would be ideal to use biochemical fusion assays to monitor the mixing of contents during fusion. Such assays have been developed in which enzymes or fluorescent probes are transferred from a donor membrane-bound compartment to an acceptor compartment; dequenching of the fluorescence of octadecyl rhodamine dye (R18) has been particularly successful for monitoring lipid mixing during fusion (reviewed in references 3 and 10). The R18 assay has been used successfully for monitoring the cell fusion mediated by the influenza virus HA when expressed in CV-1 cells from an SV40 vector (6) . However, the assay could not be used successfully for the SV5 F proteins mutants described here. One explanation for this failure to obtain positive data from the assay is that the paramyxovirus F protein lacks the receptor-binding activity (hemagglutination) normally provided by the HN glycoprotein (and that is an inherent property of influenza virus HA) and thus there was no means of attaching the R18 loaded erythrocytes to the CV-1 cells expressing F.
The three SV5 F glycine mutants, G3A, G7A, and G12A, all resulted in increased syncytium-inducing activity. Although both alanine and glycine are small neutral, aliphatic amino acids, this change in mutants G7A and G12A had a drastic effect on the transport and maturation of the F protein as well as the fusion activity. Not only was the fusion activity of the glycine mutants increased, but the low level of cleavage and cell surface expression of these F mutants suggests that the specific activity of these molecules is greatly increased. The simplest interpretation of these data is that the F peptide is directly involved in syncytium formation. A two-to threefold increase in fusion activity of the SIV gp32 has been found when alanine was substituted for glycine, and it was suggested that the introduction of alanine increased the hydrophobicity of the F peptide, stabilizing its lipid interaction (4) . As the SV5 F protein mutants A1oV and V131 do cause an increase in hydrophobicity as measured by most criteria but do not exhibit increased fusogenic activity over wt F, these factors suggest that fusion activity involves more than increased hydrophobicity.
Although an X-ray structural determination of the paramyxovirus F protein has yet to be made, several studies suggest the fusion peptide forms an a-helix. The circular dichroism spectrum of the detergent-solubilized Sendai virus F protein indicated a greater a-helical component in the cleaved form than in the uncleaved form, concomitant with an increase in hydrophobicity of the protein (20) . Additionally, synthetic peptides corresponding to the F1 N-terminal domain of Newcastle disease virus increased their helicity and assumed an oblique transmembrane orientation when interacting with lipids (5). This orientation is also inferred for the SIV gp32 N terminus as mutations which, in theory, modify the potential to form an obliquely oriented a-helix caused a reduced fusion potential (17) . For the influenza virus HA, a direct demonstration of the HA2 N terminus interacting with the lipid bilayer was provided by transfer of label from a photoactive hydrophobic probe to the HA2 N terminus, and the labeling pattern suggested that the domain was inserted into the membrane as an a-helix (14) . In conjunction with the glycine-to-alanine mutants described here, it is worth noting that in a study of the helical C peptide of RNase A, when internal alanine residues were converted to glycine residues the a-helix was substantially destabilized (59) . The substitution of glycine to alanine was found to increase the thermostability of three naturally occurring proteins: the lambda repressor, a Bacillus stearothermophilus protease, and the bacteriophage T4 lysozyme (59 and references therein). Thus, the potential for the F fusion peptide to form an a-helical structure is likely to be lessened by the presence of the helix-destabilizing glycine residues.
Host cell DNA, RNA, and protein synthesis, as well as virus production, is shut down during SV5 infection of fusion-susceptible BHK21-F cells (15) . Thus, it was not surprising to find that the extensive fusion activity of G7A and G12A correlated not only with an inhibition of protein synthesis, but also with an inability to produce high-titer SV40 stocks (data not shown). Although the detailed effect on SV40 replication was not investigated, extensive syncytium formation was observed beginning 60 h posttransfection of the SV40 F DNA, and the virus stocks had to be harvested prior to the usual time of 7 days posttransfection. The severity of the G7A and G12A cytopathic effect may provide an explanation in part for the conservation of the F protein fusion peptide amino acid sequence. The invariant amino acids in the fusion peptide may preserve a balance between high fusion activity and successful viral replication. Substitution of alanine for glycine in mutants G3A, G7A, and G12A might stabilize the formation of an a-helix, perhaps lowering some energetic barriers to bilayer fusion. However, naturally occurring G3A, G7A, and G12A mutations, as well as others which have similar fusion characteristics, may be selected against, as they would limit viral replication. While VOL. 66, 1992 on October 19, 2017 by guest http://jvi.asm.org/ many mutations in the F fusion peptide can be accommodated without loss of fusion activity in cultured cells, the conserved sequence may help to stabilize the overall molecular architecture of the F protein. It is interesting that all six naturally occurring alanine residues align on the same face of the helix (Fig. 1B) and substituting alanine for glycine may serve to extend the length of the helical face containing alanine residues. The position of these alanine residues may be an important factor in the conservation of the fusion peptide sequence in the paramyxovirus F proteins, and this remains to be determined.
